Appointment booking for Dr. Andrew Dickey, MD is currently not available.Dr. Andrew Dickey, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Andrew Dickey, MD (he/him) is a Oncologist, Internist in Cape Girardeau, MO with over 17 years of experience. What is your opinion of Dr. Andrew Dickey, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 17 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Andrew Dickey, MD has received over $2,089 which includes payments from the following companies:
$369.52 from Merck Sharp & Dohme Corporation
$323.89 from E.R. Squibb & Sons, L.L.C.
$245.80 from Novartis Pharmaceuticals Corporation
$154.44 from Celgene Corporation
$151.49 from AbbVie, Inc.
$146.50 from Medtronic USA, Inc.
$129.45 from Amgen Inc.
$121.05 from DFINE, Inc
$86.32 from GENZYME CORPORATION
$67.90 from Medivation Inc.
$64.80 from Intuitive Surgical, Inc.
$59.70 from Daiichi Sankyo Inc.
$35.64 from Incyte Corporation
$20.46 from Blue Earth Diagnostics Limited
$20.16 from Eisai Inc.
$17.53 from Exelixis Inc.
$17.24 from Helsinn Therapeutics (U.S.), Inc.
$16.85 from Covidien Sales LLC
$15.59 from Janssen Biotech, Inc.
$13.71 from Pfizer Inc.
Payments received by Dr. Andrew Dickey, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!